Loading stock data…
Sensus Healthcare, Inc. (SRTS)
$3.16-0.03 (-0.94%)
Market ClosedLast close Sep 8
Sensus Healthcare, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sensus Healthcare, Inc. in the Healthcare sector is trading at $3.16 with a market capitalization of $52M. Wall Street consensus targets $5.38 (4 analysts), implying a +70.1% move over the next 12 months. The stock is currently near its 52-week low of $2.66, remaining 15.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +70.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.39M↓ | $4.94M↓ | $6.88M↓ | $7.32M↓ | $8.34M |
| Gross Profit | $991,000↓ | $1.90M↓ | $2.71M↓ | $2.90M↓ | $4.35M |
| Operating Income | -$4.36M↓ | -$3.15M↓ | -$2.57M↓ | -$1.94M↑ | -$2.65M |
| Net Income | -$2.63M↑ | -$3.17M↓ | -$943,000↑ | -$1.04M↑ | -$2.57M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of tr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$52.02M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.14
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-42.01%
Volume
Today's trading volume
24,005
Recent News
Sensus (SRTS) Q2 2026 Earnings Call Transcript
Financing delays crushed Q2 revenue, but management expects recovery in Q3.
Sensus Healthcare Inc (SRTS) (Q2 2026) Earnings Call Highlights: Strong Pipeline and New CPT ...
Company secures delayed orders and sees growing international demand, positioning for a stronger second half.
Sensus Healthcare, Inc. Q2 2026 Earnings Call Summary
Moby summary of Sensus Healthcare, Inc.'s Q2 2026 earnings call
Sensus Healthcare Q2 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) reported second-quarter revenue of $2.3 million, down from $7.3 million a year earlier, as delayed third-party financing prevented the company from recognizing revenue tied to eight equipment units before the end of June. Chairman and Chief Executive Officer Joe Sard
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes
Sensus Healthcare’s fair value estimate has been trimmed from US$6.88 to US$5.75, putting a sharper spotlight on what analysts think the stock is worth today. That shift reflects a mix of optimism and caution, as recent research weighs the SRT-100/Vision platform and 2026 reimbursement changes against execution risk and timing. Read on to see how to interpret these updated targets and what to watch as the story continues to evolve. Stay updated as the Fair Value for Sensus Healthcare shifts...